These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28375540)

  • 21. [Substance use, affective problems and personality traits: test of two association models].
    Chakroun N; Doron J; Swendsen J
    Encephale; 2004; 30(6):564-9. PubMed ID: 15738859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The consumption of psychoactive substances by adolescents in schools in Ribeiräo Preto, SP (Brazil). I--Prevalence of consumption by sex, age and substance].
    Muza GM; Bettiol H; Muccillo G; Barbieri MA
    Rev Saude Publica; 1997 Feb; 31(1):21-9. PubMed ID: 9430923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterizing users of new psychoactive substances using psychometric scales for risk-related behavior.
    Vreeker A; van der Burg BG; van Laar M; Brunt TM
    Addict Behav; 2017 Jul; 70():72-78. PubMed ID: 28214739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of psychiatric inpatients diagnosed with mental and behavioral disorders caused by psychoactive substances (F11-19 block), with a focus on NPS and psychiatric co-morbidities.
    Engelgardt P; Krzyżanowski M; Piotrowski P; Borkowska-Sztachańska M; Wasilewska A; Kowalkowski T
    Int J Occup Med Environ Health; 2020 Mar; 33(2):125-136. PubMed ID: 31942874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.
    Deligianni E; Daniel OJ; Corkery JM; Schifano F; Lione LA
    Br J Clin Pharmacol; 2020 Mar; 86(3):505-516. PubMed ID: 31495968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dental profile of a community of recovering drug addicts: Biomedical aspects. Retrospective cohort study.
    Mateos-Moreno MV; Del-Río-Highsmith J; Riobóo-García R; Solá-Ruiz MF; Celemín-Viñuela A
    Med Oral Patol Oral Cir Bucal; 2013 Jul; 18(4):e671-9. PubMed ID: 23722124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life of users of psychoactive substances, relatives, and non-users assessed using the WHOQOL-BREF.
    Moreira Tde C; Figueiró LR; Fernandes S; Justo FM; Dias IR; Barros HM; Ferigolo M
    Cien Saude Colet; 2013 Jul; 18(7):1953-62. PubMed ID: 23827899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral health status of heroin users in a rehabilitation centre in Hubei province, China.
    Du M; Bedi R; Guo L; Champion J; Fan M; Holt R
    Community Dent Health; 2001 Jun; 18(2):94-8. PubMed ID: 11461065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of psychoactive substances, alcohol and illicit drugs, in Spanish drivers: A roadside study in 2015.
    Domingo-Salvany A; Herrero MJ; Fernandez B; Perez J; Del Real P; González-Luque JC; de la Torre R
    Forensic Sci Int; 2017 Sep; 278():253-259. PubMed ID: 28778032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral lesions of 500 habitual psychoactive substance users in Chennai, India.
    Thavarajah R; Rao A; Raman U; Rajasekaran ST; Joshua E; R H; Kannan R
    Arch Oral Biol; 2006 Jun; 51(6):512-9. PubMed ID: 16412976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perceived harmfulness of substance use: a pilot study.
    Sarkar S; Balachander S; Basu D
    Indian J Community Med; 2014 Jan; 39(1):26-9. PubMed ID: 24696536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of tightening regulations on patients with new psychoactive substance-related disorders in Japan.
    Tanibuchi Y; Matsumoto T; Funada D; Shimane T
    Neuropsychopharmacol Rep; 2018 Dec; 38(4):189-196. PubMed ID: 30341809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motives of abuse of psychoactive substances by women assisted in a Psychosocial Attention Center.
    Soccol KLS; Terra MG; Padoin SMM; Ribeiro DB; Siqueira DF; Canabarro JL
    Rev Gaucha Enferm; 2018 Oct; 39():e20170281. PubMed ID: 30365755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing intentions to reduce substance use and willingness to seek help among transgender and cisgender participants from the Global Drug Survey.
    Connolly D; Davies E; Lynskey M; Barratt MJ; Maier L; Ferris J; Winstock A; Gilchrist G
    J Subst Abuse Treat; 2020 May; 112():86-91. PubMed ID: 32199550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultra-High Performance Liquid Chromatography-High Resolution Mass Spectrometry and High-Sensitivity Gas Chromatography-Mass Spectrometry Screening of Classic Drugs and New Psychoactive Substances and Metabolites in Urine of Consumers.
    Marchei E; Ferri MA; Torrens M; Farré M; Pacifici R; Pichini S; Pellegrini M
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Awareness of users and motivational factors for using new psychoactive substances in Belgium.
    Simonis S; Canfyn M; Van Dijck A; Van Havere T; Deconinck E; Blanckaert P; Gremeaux L
    Harm Reduct J; 2020 Jul; 17(1):52. PubMed ID: 32711526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcohol, psychoactive substances and non-fatal road traffic accidents--a case-control study.
    Bogstrand ST; Gjerde H; Normann PT; Rossow I; Ekeberg Ø
    BMC Public Health; 2012 Sep; 12():734. PubMed ID: 22943663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of, Factors Associated with and Level of Dependence of Psychoactive Substance Use among Mekelle University Students, Ethiopia.
    Gebresilassie Tesema A; Hadush Kahsay Z; Gidey Lemma G; Hagos Gebretsadik W; Mussie Weldemaryam M; Gebregiorgis Alemayohu G; L Hackett M
    Int J Environ Res Public Health; 2020 Jan; 17(3):. PubMed ID: 32013178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Family health and the use of psychoactive substances.
    Hsu LN
    World Health Stat Q; 1993; 46(4):237-41. PubMed ID: 8017084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.